Simultaneous determination of apatinib a
✍
Juefang Ding; Xiaoyan Chen; Xiaojian Dai; Dafang Zhong
📂
Article
📅
2012
🏛
Elsevier Science
🌐
English
⚖ 754 KB
Apatinib, also known as YN968D1, is a novel antiangiogenic agent that selectively inhibits vascular endothelial growth factor receptor-2. Currently, apatinib is undergoing phase II/III clinical trials in China for the treatment of solid tumors. Apatinib is extensively metabolized in humans, and its